Zhe Wang1, Wai-Keung Chui, Paul C Ho. 1. Department of Pharmacy, National University of Singapore, 18 Science Drive 4, Singapore, 117543, Singapore.
Abstract
PURPOSE: Several individual approaches were combined to fabricate a novel nanoparticulate drug delivery system to achieve targeting and anticancer effects in various malignant cancer cells. METHODS: Doxorubicin was conjugated to Poly(lactic-co-glycolic acid) (PLGA), which was formulated into nanoparticle via solvent-diffusion method. The surface of the nanoparticles was subsequently linked with Poly(ethylene glycol) (PEG) and Arg-Gly-Asp (RGD) peptide to realize both passive and active targeting functions. The multifunctional nanoparticles were then tested against several malignant cancer cell lines. RESULTS: The conjugation increased loading efficiency of doxorubicin to PLGA nanoparticles (the encapsulation efficiency was over 85%) and alleviated the drug burst release effect substantially. The drug was released from the polymeric matrix in a sustained release manner over a period of 12 days. The resultant nanoparticles were spherically uniform and well-dispersed. The nanoparticle targeting ability was proven through strong affinity to various integrin-expressing cancer cells, and much less affinity to the low integrin expression cancer cells. The nanoparticles also showed high efficacy in inducing apoptosis in specific malignant cancer cell. CONCLUSION: The developed multifunctional nanoparticles hold potential to treat malignant integrin-expressing cancers.
PURPOSE: Several individual approaches were combined to fabricate a novel nanoparticulate drug delivery system to achieve targeting and anticancer effects in various malignant cancer cells. METHODS:Doxorubicin was conjugated to Poly(lactic-co-glycolic acid) (PLGA), which was formulated into nanoparticle via solvent-diffusion method. The surface of the nanoparticles was subsequently linked with Poly(ethylene glycol) (PEG) and Arg-Gly-Asp (RGD) peptide to realize both passive and active targeting functions. The multifunctional nanoparticles were then tested against several malignant cancer cell lines. RESULTS: The conjugation increased loading efficiency of doxorubicin to PLGA nanoparticles (the encapsulation efficiency was over 85%) and alleviated the drug burst release effect substantially. The drug was released from the polymeric matrix in a sustained release manner over a period of 12 days. The resultant nanoparticles were spherically uniform and well-dispersed. The nanoparticle targeting ability was proven through strong affinity to various integrin-expressing cancer cells, and much less affinity to the low integrin expression cancer cells. The nanoparticles also showed high efficacy in inducing apoptosis in specific malignant cancer cell. CONCLUSION: The developed multifunctional nanoparticles hold potential to treat malignant integrin-expressing cancers.
Authors: Twan Lammers; Peter Peschke; Rainer Kühnlein; Vladimir Subr; Karel Ulbrich; Peter Huber; Wim Hennink; Gert Storm Journal: Neoplasia Date: 2006-10 Impact factor: 5.715
Authors: Mijin Kim; Jessica Liao; Melissa L Dowling; K Ranh Voong; Sharon E Parker; Shulin Wang; Wafik S El-Deiry; Gary D Kao Journal: Cancer Res Date: 2008-05-01 Impact factor: 12.701
Authors: P A Vasey; S B Kaye; R Morrison; C Twelves; P Wilson; R Duncan; A H Thomson; L S Murray; T E Hilditch; T Murray; S Burtles; D Fraier; E Frigerio; J Cassidy Journal: Clin Cancer Res Date: 1999-01 Impact factor: 12.531
Authors: Patrick M Winter; Shelton D Caruthers; Andrea Kassner; Thomas D Harris; Lori K Chinen; John S Allen; Elizabeth K Lacy; Huiying Zhang; J David Robertson; Samuel A Wickline; Gregory M Lanza Journal: Cancer Res Date: 2003-09-15 Impact factor: 12.701
Authors: Jun Qian; Elsie Oppermann; Andreas Tran; Ulli Imlau; Kun Qian; Thomas Josef Vogl Journal: World J Gastroenterol Date: 2016-06-07 Impact factor: 5.742
Authors: Eric M Bressler; Jayoung Kim; Ron B Shmueli; Adam C Mirando; Hojjat Bazzazi; Esak Lee; Aleksander S Popel; Niranjan B Pandey; Jordan J Green Journal: J Biomed Mater Res A Date: 2018-02-23 Impact factor: 4.396